REGistry of Long-term AnTithrombotic TherApy-1

Registry Dedicated to Assess the Risk of Ischemic and Hemorrhagic Complications of Long-term Antithrombotic Therapy in Patients With Chronic Coronary Syndromes

To assess the rates of ischemic and hemorrhagic complications of long-term antithrombotic therapy in patients with chronic coronary syndromes

The register is a Russian prospective single-center observational study of patients who have indications for long-term antithrombotic therapy in connection with chronic coronary syndromes

Inclusion Criteria:

• coronary artery disease , confirmed by history of myocardial infarction, or revascularization, or definitive evidence of CAD on imaging

Exclusion Criteria:

• Subjects who are unwilling or unable to provide informed consent.
• Acute coronary syndrome within 12 months before inclusion
• Severe chronic heart failure (NYHA IV)
• Stroke within 6 months before inclusion
• Severe liver or muscle disease
• Severe kidney disease / renal failure with creatinine > 3 mg/dl
• Conceivable impossibility to come in touch with the patient or his family at 1-year after the intervention -